![Anna Berkenblit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Berkenblit
Direttore/Membro del Consiglio presso
SURROZEN, INC.
Patrimonio netto: 51 994 $ in data 31/07/2026
Profilo
Anna Berkenblit currently serves as Director at Surrozen Operating, Inc. since 2019, Independent Director at Surrozen, Inc. since 2018, Director at Nested Therapeutics, Inc., and Chief Scientific & Medical Officer at Pancreatic Cancer Action Network, Inc. Former roles include Chief Medical Officer & Senior Vice President at ImmunoGen, Inc. from 2019 to 2023, Vice President at Pfizer Inc. from 2007 to 2011, Vice President & Head-Clinical Research at AVEO Pharmaceuticals, Inc. from 2011 to 2013, and Senior Vice President-Clinical Development at H3 Biomedicine, Inc. from 2013 to 2015.
Education includes graduate degrees from Harvard University and Massachusetts Institute of Technology, an undergraduate degree from Yale University, and a doctorate from Harvard Medical School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SURROZEN INC 0,02% | 13/05/2026 | 2.341 ( 0,02% ) | 51 994 $ | 31/07/2026 |
Posizioni attive di Anna Berkenblit
| Società | Posizione | Inizio |
|---|---|---|
| SURROZEN, INC. | Direttore/Membro del Consiglio | 01/08/2018 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direttore/Membro del Consiglio | 14/03/2019 |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Direttore/Membro del Consiglio | - |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Anna Berkenblit
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOGEN, INC. | Direttore Tecnico/Scientifico/R&S | 31/08/2023 |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Corporate Officer/Principal | 01/01/2015 |
| AVEO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
| PFIZER INC. | Corporate Officer/Principal | 01/09/2011 |
Formazione di Anna Berkenblit
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Commercial Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Commercial Services |
